Deep Origin awarded $31.7M ARPA-H contract to replace animal testing with in-silico models. Learn more

Accelerating Drug Discovery with Physics-Informed Machine Learning

Deep Origin Research Team
Drug Discovery Chemistry 2025 (Barcelona) November 11, 2025

Deep Origin researchers present advances in computational drug discovery combining physics-informed machine learning with large-scale biochemical datasets to improve molecular docking accuracy and binding predictions.

The Challenge

Advances in scale have outpaced improvements in accuracy in virtual screening. This poster demonstrates how physics-informed ML models can achieve substantial gains in pose accuracy, affinity rank-ordering, and early enrichment across retrospective benchmarks.

Technical Focus Areas

  • Pose prediction improvements - Enhanced accuracy in predicting molecular binding poses
  • Binding-affinity estimation - More reliable predictions of how strongly molecules bind to targets
  • Out-of-distribution performance - Strong results on challenging targets including CD73
  • End-to-end integration - Seamless pipeline spanning docking, property prediction, virtual screening, reinforcement learning, and molecular dynamics

Delivery Methods

Our physics-informed ML capabilities are available through:

  • Python API - Full programmatic access for computational scientists
  • Balto AI - Natural-language interface for molecular modeling, making cutting-edge tools accessible to all researchers